Specify a stock or a cryptocurrency in the search bar to get a summary
Enzymatica publ AB
ENZYEnzymatica AB (publ), a life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract. The company's product includes ColdZyme, a mouth spray to treat and alleviate cold and flu symptoms. It also provides enzyme formulations for skin care. The company offers its products through contract organizations and partner agreements with distributors who sell the products under the ViruProtect, STADAProtect, and Bisolviral brand names. Enzymatica AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. Address: Ideon Science Park, Lund, Sweden, 223 70
Analytics
WallStreet Target Price
42.16 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ENZY
Dividend Analytics ENZY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENZY
Stock Valuation ENZY
Financials ENZY
Results | 2019 | Dynamics |